Results of the Intergroup Rhabdomyosarcoma Study Group D9602 protocol, using vincristine and dactinomycin with or without cyclophosphamide and radiation therapy, for newly diagnosed patients with low-risk embryonal rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
Source:http://linkedlifedata.com/resource/pubmed/id/21357783
J. Clin. Oncol.
2011
Apr
1
29
10
1312-8
